Cybeats Announces Date for First Quarter Fiscal 2026 Financial Results
MyFlyYatra Expanding San Francisco to India Flight Route for Travelers with Economy, Premium, Business and First-Class Travel
SpendLayer Announces Official Platform Launch on 28 May 2026
Backstageplay to Acquire Software, IP, and Databases from NeXT Sports Group
Paragon Advanced Labs Provides Corporate Update
KPI Integrated Solutions and Phononic form a strategic partnership to answer the demand for cold…
JERSEY CITY, N.J., June 23, 2022 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology…
New analyses of PEDFIC Phase 3 trials show that patients whose pruritus improves on Bylvay® (odevixibat)…
IRVINE, Calif., June 23, 2022 (GLOBE NEWSWIRE) — Biomerica Inc. (NASDAQ: BMRA) today announced that…
Cullinan Oncology receives upfront cash payment of $275 million, with potential to receive up to…
CAMBRIDGE, United Kingdom and NEW YORK, June 23, 2022 (GLOBE NEWSWIRE) — Artios Pharma Limited…
VANCOUVER, British Columbia, June 23, 2022 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the…
WINSTON-SALEM, N.C., June 23, 2022 (GLOBE NEWSWIRE) — ProKidney LP (ProKidney), a leading clinical-stage cellular…
LOS ANGELES, June 23, 2022 (GLOBE NEWSWIRE) — Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical…
MUNICH, Germany, June 23, 2022 (GLOBE NEWSWIRE) — HMNC Brain Health (“HMNC” or the “Company”),…
CARSON CITY, Nev., June 23, 2022 (GLOBE NEWSWIRE) — BioVie Inc. (NASDAQ: BIVI) (“BioVie” or “Company”), a…
Pivotal Trial Expected to Enroll More Than 140 Patients With Moderate to Severe Congenital Ichthyosis…
Orders Received from Two New Jurisdictions, and a Country in the Asia Pacific Region under…
– Study Supported by $30M NIA Grant Award and Conducted in Collaboration with University of…
COPENHAGEN, Denmark, June 23, 2022 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or…
Positive effects on oxygenation observed with the 2.5 mg/kg dose at the end of the…
Bar Chart Bar Chart ~ Treatment generally well-tolerated with no significant safety issues related to…
-Former CEO of Dicerna brings deep expertise in RNA research, drug development, business development and…
83% of Respondents With Acute COVID Were Satisfied 68% of Respondents With Long COVID Were…
WALTHAM, Mass., June 23, 2022 (GLOBE NEWSWIRE) — Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology…